General MedicationsINJECTIONGeneric

MITOZYTREX

MITOMYCIN

Standard Dose

5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview MITOZYTREX is listed in Drugs@FDA under application 050763 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient MITOMYCIN Form and strength INJECTABLE;INJECTION - 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SUPERGEN Submission history Latest submission status date: 2002-11-14 00:00:00.

Structured Monograph

Clinical summary

Approval overview MITOZYTREX is listed in Drugs@FDA under application 050763 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MITOMYCIN Form and strength INJECTABLE;INJECTION - 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor SUPERGEN Submission history Latest submission status date: 2002-11-14 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.